Vimian Group AB (publ) (“Vimian”, the “Group” or the “Company”), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, today announces the listing of and commencement of trading in its ordinary shares on Nasdaq First North Growth Market (the “Listing”). Immediately prior to the Listing, Vimian carried out a Private Placement of existing and newly issued shares to domestic and international qualified investors (the “Private Placement”). The Private Placement attracted very strong interest from high-quality institutional investors, including SEK 5.1 billion in cornerstone investments as previously announced, and was oversubscribed multiple times. Trading on Nasdaq First North Growth Market commences today on 18 June 2021.
For more information, please visit: www.vimian.com.
Vimian Group AB (publ), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, announces its intention to carry out a private placement of shares in theRead more
Following a decade of successfully shaping market leaders across the rapidly evolving animal health market, Fidelio Capital AB (Fidelio) today announced the formation of Vimian – a global and diversified group of innovation-driven companies operating in four fast-growing animal healthRead more
Indical has acquired the Svanova product portfolio from Boehringer Ingelheim. Through the acquisition, Indical becomes the exclusive provider of Svanova’s veterinary testing products, which include around 25 livestock ELISA assays. Svanova arose out of the Swedish Veterinary Institute, a pioneerRead more